Skip to content

Sleep Revive Review: Six Ingredients, Checked Against The Sleep Trials

Affiliate disclosure: This article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. This does not influence our assessment of the evidence below.

Evidence rating: Moderate — every active ingredient has randomized human sleep data behind it, though two of them sit well below the doses that produced the results

What Sleep Revive Claims To Be

Sleep Revive is a nightly capsule aimed at people who fall asleep fine but wake at 3 a.m., or who sleep a full night and still feel flat in the morning. The pitch goes beyond sedation: it frames deep sleep as the window for “overnight metabolic repair,” with an amino acid pair included specifically to nudge growth hormone release during that window.

Unusually for this category, the label is fully open — every ingredient carries a stated milligram amount. That alone puts it ahead of most competitors, because it lets you do exactly what this review is about to do: compare what’s in the bottle against what was tested.

What’s Actually In It

Per serving:

  • L-Arginine — 500 mg
  • L-Lysine — 250 mg
  • Ashwagandha Root Extract — 150 mg
  • L-Theanine — 100 mg
  • 5-HTP — 50 mg
  • Melatonin — 3 mg

Three of these (ashwagandha, theanine, melatonin) are the genuine sleep actives. 5-HTP is a serotonin precursor, and the arginine/lysine pair is there for the growth hormone angle rather than for sleep itself.

What The Research Shows

According to PubMed, the sleep-supplement literature is unusually well populated — and it gives a mixed but net-positive picture for this particular combination.

Ashwagandha has the strongest evidence in the bottle. A systematic review and meta-analysis of five randomized controlled trials in 400 participants found ashwagandha extract produced a small but statistically significant improvement in overall sleep (standardised mean difference −0.59, 95% CI −0.75 to −0.42), plus better mental alertness on waking and lower anxiety. No serious side effects were reported. DOI

But the dose here is a quarter of what worked best. That same meta-analysis found the effects were most prominent at ≥600 mg/day for ≥8 weeks. Sleep Revive contains 150 mg. That doesn’t mean 150 mg does nothing — it means you shouldn’t expect the meta-analysis result from this dose.

One trial did test doses in this range, with modest results. A 90-day randomized double-blind study in 52 adults with sleep problems compared enriched milk containing 250 mg or 600 mg ashwagandha (with or without tryptophan) against control. All three ashwagandha groups improved significantly more than control on a visual analogue sleep-quality scale (p = 0.014), with the largest drops in insomnia severity in the 600 mg group. Notably, adding tryptophan produced no additional benefit over ashwagandha alone — worth remembering when you see 5-HTP in a stack. DOI

The best single ashwagandha trial used 8 weeks and measured objectively. In 80 participants — 40 healthy, 40 with insomnia — ashwagandha root extract significantly improved sleep onset latency and sleep efficiency, with total sleep time and wake-after-sleep-onset also improving. Effects were considerably stronger in the insomnia group than the healthy one, and the extract was well tolerated. DOI

L-theanine’s evidence is real but soft, and mostly subjective. An 8-week double-blind randomized trial of a Lactium plus L-theanine supplement in 40 adults with sleep complaints found no significant difference between groups on the two headline questionnaires (Pittsburgh Sleep Quality Index, Insomnia Severity Index). Daily sleep-diary analysis did show significant within-group improvements on wake-after-sleep-onset counts and bedtime in the supplement group. DOI

And when theanine was measured with EEG, the objective numbers didn’t move. A randomized, placebo-controlled, double-blind trial of daily matcha (50.3 mg theanine) for 4 weeks found no significant differences versus control in total sleep time, sleep latency, wake after sleep onset, or sleep efficiency on electroencephalography — although subjective satisfaction with sleep trended upward and wake-up time shortened significantly. DOI

Melatonin is not universally effective either. A Cochrane review of drug treatments for sleep disturbance in dementia found low-certainty evidence that melatonin at doses up to 10 mg “may have little or no effect on any major sleep outcome” over 8-10 weeks — no significant benefit on total nocturnal sleep time, sleep efficiency, wake after sleep onset, or number of awakenings. That’s a specific population, not a general verdict, but it’s a useful corrective to melatonin’s reputation as a sure thing. DOI

The Honest Verdict

What holds up: The formula is built from ingredients that actually have randomized trial data, not filler botanicals. Ashwagandha in particular has meta-analytic support for sleep quality and morning alertness, with a good tolerability record. Melatonin at 3 mg is a sensible, conservative dose — lower than the 5-10 mg megadoses that tend to cause grogginess. Full dose disclosure is a genuine mark in this product’s favor.

What doesn’t: The 150 mg of ashwagandha is well under the ≥600 mg that drove the strongest results. The theanine evidence is largely subjective — the two trials cited found no objective EEG or questionnaire-level differences. And the “metabolic repair” and growth-hormone framing around arginine and lysine is the weakest claim on the label; none of the sleep trials retrieved here tested that pathway, and it should be read as marketing theory rather than demonstrated benefit.

Who this makes sense for: Someone with mild, stress-flavored sleep trouble — a busy mind at bedtime, restless nights during a rough stretch — who wants a low-risk, transparently dosed option. The trials suggest committing for at least 8 weeks before deciding, since that’s where effects consolidated.

Who should skip it: Anyone taking an SSRI, SNRI, MAOI, tramadol, or triptan — 5-HTP raises serotonin and combining it with serotonergic medication is a real interaction to discuss with a pharmacist first, not an afterthought. Pregnant or breastfeeding women should avoid ashwagandha. And chronic insomnia lasting months, loud snoring with daytime sleepiness, or waking gasping are signals for a sleep assessment — cognitive behavioral therapy for insomnia consistently outperforms every supplement in this article, and sleep apnea does not respond to capsules.

Check current pricing and availability

View Sleep Revive on the official site

This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Talk to your physician before starting any supplement, especially if you have a diagnosed condition or take medication.

Research cited via PubMed:

  • Cheah KL, et al. PLoS One. 2021;16(9):e0257843. DOI
  • Pérez-Piñero S, et al. Clocks Sleep. 2024;6(3):417-432. DOI
  • Langade D, et al. J Ethnopharmacol. 2021;264:113276. DOI
  • Lim SE, et al. Front Nutr. 2024;11:1419978. DOI
  • Baba Y, et al. Nutrients. 2024;16(17):2907. DOI
  • McCleery J, Sharpley AL. Cochrane Database Syst Rev. 2020;11:CD009178. DOI

Leave a Reply

Your email address will not be published. Required fields are marked *